Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Prepaid Assets (2021 - 2025)

InMed Pharmaceuticals (INM) has 5 years of Prepaid Assets data on record, last reported at $660280.0 in Q4 2025.

  • For Q4 2025, Prepaid Assets rose 2.53% year-over-year to $660280.0; the TTM value through Dec 2025 reached $660280.0, up 2.53%, while the annual FY2025 figure was $321747.0, 32.65% down from the prior year.
  • Prepaid Assets reached $660280.0 in Q4 2025 per INM's latest filing, up from $191755.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $1.3 million in Q1 2022 and bottomed at $140512.0 in Q4 2021.
  • Average Prepaid Assets over 5 years is $569300.5, with a median of $502952.5 recorded in 2023.
  • Peak YoY movement for Prepaid Assets: surged 488.51% in 2022, then tumbled 50.14% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $140512.0 in 2021, then soared by 488.51% to $826931.0 in 2022, then surged by 34.59% to $1.1 million in 2023, then tumbled by 42.14% to $643986.0 in 2024, then grew by 2.53% to $660280.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $660280.0 in Q4 2025, $191755.0 in Q3 2025, and $321747.0 in Q2 2025.